FDA Pulls Cancer Drug Approvals Due to Safety Concerns
FDA Pulls Cancer Drug Approvals Due to Safety Concerns Safety concerns have prompted the FDA to withdraw approval of umbralisib (Ukoniq) On June 1, 2022, the U.S. Food and Drug Administration withdrew its approval for…